Mustang Bio
MBIO
67 hedge funds and large institutions have $6.8M invested in Mustang Bio in 2022 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 10 increasing their positions, 24 reducing their positions, and 12 closing their positions.
0% less ownership
Funds ownership: 0.02% → 0.02% (-0%)
6% less funds holding
Funds holding: 71 → 67 (-4)
25% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 12
34% less capital invested
Capital invested by funds: $10.3M → $6.8M (-$3.52M)
58% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 24
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$298K |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
+$106K |
| 3 |
WWM
Western Wealth Management
Golden,
Colorado
|
+$55.6K |
| 4 |
OC
Oppenheimer & Co
New York
|
+$46.8K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$35.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$941K |
| 2 |
Renaissance Technologies
New York
|
-$417K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$342K |
| 4 |
Millennium Management
New York
|
-$204K |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
-$145K |
MBIO Hedge Fund Activity: Q3 2022 in Review
67 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in Mustang Bio (MBIO) for Q3 2022, worth a combined $6.8M — down 34% from $10.3M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of MBIO and 9 opened new positions — a net loss of 3 holders — while 24 trimmed existing stakes and 10 added.
The largest buyer was Vanguard Group, adding an estimated $298K. The largest seller was JP Morgan Chase, cutting an estimated $941K.
- 67 institutional investors held Mustang Bio (MBIO) as of Q3 2022, down from 71 in Q2 2022.
- Funds reported $6.8M of Mustang Bio stock for Q3 2022, down 34% quarter-over-quarter.
- 9 funds opened new Mustang Bio positions in Q3 2022 and 12 closed out, a net change of -3 holders.
- The largest Mustang Bio buyer in Q3 2022 was Vanguard Group, an estimated $298K added.
- The largest Mustang Bio seller in Q3 2022 was JP Morgan Chase, an estimated $941K sold.
Based on aggregated 13F filings for Q3 2022.